Über das Unternehmen
- Firmenname (rechtlich): Chifeng Eyeris Company Ltd.,
- Internationaler Name: Chifeng Eyeris Co., Ltd., Chifeng, Inner Mongolia, China
- Marke / Handelsname: Eyeris
- Registrierungsland: Mongolia
- Adresse: Inner Mongolia Autonomous RegionChifengRoom 201, Building 14, Zone B, Mengdong Cloud Computing Industrial Park, Logistics Park, Hongshan District, Chifeng City, Inner Mongolia Autonomous Region
- Gründungsjahr: 2017
Chifeng Eyeris Company Ltd., established in 2017 and based in Hongshan District, Chifeng City, Inner Mongolia, operates as an agent, exporter, trading company and retailer of active pharmaceutical ingredients, pharmaceutical excipients, API and preparation equipment, and pharmaceutical packaging machinery, alongside veterinary drugs and feed and fine chemicals, selling to Asia, the Middle East, Africa and Central/South America. Its team brings more than 20 years of combined experience in APIs, chemicals and pharmaceutical equipment and deep familiarity with the Chinese pharmaceutical market, offering customers advantages in pricing, quality, market intelligence, technology updates, new-product launches and local formulation expansion. The company provides CSO contract sales services and is recognized for its brand, international certification, experienced R&D personnel, delivery speed, good reputation, and acceptance of small orders and buyer-specific requirements.
Geschäftsaktivitäten
Pharmazeutische Chemikalien
Tierarzneimittel & Futtermittelzusatzstoffe
Produktionsanlagen & Betriebstechnik
Hilfsstoffe & Zusatzstoffe
Pharmazeutische Wirkstoffe (API)
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Western Asia: United Arab Emirates, Armenia, Azerbaijan, Bahrain
- Pharmazeutische Wirkstoffe (API): Furaltadone HCl, 地塞米松磷酸钠 Dexamethasone Sodium Phosphate, AZITHROMYCIN, Paracetamol, Active Pharmaceutical Ingredients, Ofloxacin, Valsartan, Norfloxacin, LINCOMYCIN HCL, Tranexamic Acid, CEPHRADINE ®, Tylosin Tartrate, Colistin Sulfate, Amantadine HCL, Colistimethate Sodium, Levofloxacin, piracetam, Fosfomycin Calcium, Metronidazole, (+)-Griseofulvin, Benzylpenicillin sodium, Calcium Chloride, Clarithromycin, Dextrose Anhydrous, Hydroxychlorquine Sulphate, ’Mefenamic Acid, Oxytetracycline HCL, Permethrin, Potassium Chloride, Sodium chloride, SULPHADIAZINE, Sulphadoxine
- Fertigarzneiformen: Florfenicol, OXFENDAZOLE
- Verpackungsmaterialien: Food packaging materials
- Pharmazeutische Chemikalien: Saccharin Sodium, Pharmaceutical Intermediates, Sodium Benzoate, DL-Tartaric acid, Dimethylacetamide (DMAC), Methyl 2-oxo-1-pyrrolidineacetate
- ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch): Empagliflozin
- Tierarzneimittel & Futtermittelzusatzstoffe: Veterinary raw materials
Unsere Produkte & Dienstleistungen
Bewertungen
Kommentare
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen